These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 25229717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early 7,8-Dihydroxyflavone Administration Ameliorates Synaptic and Behavioral Deficits in the Young FXS Animal Model by Acting on BDNF-TrkB Pathway.
    Chen YS, Zhang SM, Tan W, Zhu Q, Yue CX, Xiang P, Li JQ, Wei Z, Zeng Y.
    Mol Neurobiol; 2023 May; 60(5):2539-2552. PubMed ID: 36680734
    [Abstract] [Full Text] [Related]

  • 5. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
    Henderson C, Wijetunge L, Kinoshita MN, Shumway M, Hammond RS, Postma FR, Brynczka C, Rush R, Thomas A, Paylor R, Warren ST, Vanderklish PW, Kind PC, Carpenter RL, Bear MF, Healy AM.
    Sci Transl Med; 2012 Sep 19; 4(152):152ra128. PubMed ID: 22993295
    [Abstract] [Full Text] [Related]

  • 6. Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging.
    Zeng Y, Liu Y, Wu M, Liu J, Hu Q.
    J Alzheimers Dis; 2012 Sep 19; 31(4):765-78. PubMed ID: 22710915
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BDNF in fragile X syndrome.
    Castrén ML, Castrén E.
    Neuropharmacology; 2014 Jan 19; 76 Pt C():729-36. PubMed ID: 23727436
    [Abstract] [Full Text] [Related]

  • 10. Relationship Between Synaptic AMPAR and Spine Dynamics: Impairments in the FXS Mouse.
    Suresh A, Dunaevsky A.
    Cereb Cortex; 2017 Aug 01; 27(8):4244-4256. PubMed ID: 28541473
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.
    Jawaid S, Kidd GJ, Wang J, Swetlik C, Dutta R, Trapp BD.
    Glia; 2018 Apr 01; 66(4):789-800. PubMed ID: 29274095
    [Abstract] [Full Text] [Related]

  • 16. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.
    Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF.
    Proc Natl Acad Sci U S A; 2011 Feb 08; 108(6):2587-92. PubMed ID: 21262808
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome.
    Pyronneau A, He Q, Hwang JY, Porch M, Contractor A, Zukin RS.
    Sci Signal; 2017 Nov 07; 10(504):. PubMed ID: 29114038
    [Abstract] [Full Text] [Related]

  • 19. Utility of 7,8-dihydroxyflavone in preventing astrocytic and synaptic deficits in the hippocampus elicited by PTSD.
    Wang J, Gao F, Cui S, Yang S, Gao F, Wang X, Zhu G.
    Pharmacol Res; 2022 Feb 07; 176():106079. PubMed ID: 35026406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.